---
title: "United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports $5.51 Million Common Share Sale"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306020863.md"
description: "United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Nov. 17, 2026, generating $5.51 million. She also exercised stock options for the same number of shares at $117.76 per share. Post-transaction, her trusts held 324,443 shares, while direct holdings totaled 40,513 shares."
datetime: "2026-11-18T21:41:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306020863.md)
  - [en](https://longbridge.com/en/news/306020863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306020863.md)
generator: "portal-rs"
---

# United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports $5.51 Million Common Share Sale

-   United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Nov. 17, 2026. \* Rothblatt also exercised stock options for 9,500 common shares at $117.76 per share. \* Following the transactions, the transacting trusts held 324,443 common shares; her direct holdings totaled 40,513 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000191), on November 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)

## Related News & Research

- [United Therapeutics Authorizes New $2 Billion Share Buyback Program](https://longbridge.com/en/news/302702990.md)
- [Is United Therapeutics (UTHR) Undervalued On Earnings And Its $2b Buyback?](https://longbridge.com/en/news/304738402.md)
- [What Elevance Health Holders Got Right](https://longbridge.com/en/news/306380588.md)
- [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md)
- [United Therapeutics Corporation $UTHR Shares Purchased by AIA Group Ltd](https://longbridge.com/en/news/304413972.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**